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Abstract.  Cadherins,  a family of Ca-dependent adhe- 
sion molecules, have been proposed to act as regula- 
tors of morphogenetic processes and to be major 
effectors in the maintenance of tissue integrity.  In this 
study, we have compared the effects of the expression 
of two truncated cadherins during  early neurogenesis 
in Xenopus laevis, mRNA encoding deleted forms of 
XB- and N-cadherin lacking most of the extracellular 
domain were injected into the four animal dorsal 
blastomeres of 32-cell stage Xenopus embryos. These 
truncated cadherins  altered the cohesion of cells de- 
rived from the injected blastomeres and induced mor- 
phogenetic defects in the anterior neural tissue to 
which they chiefly contributed.  Truncated XB- 
cadherin was more efficient than N-cadherin in induc- 
ing these perturbations.  Moreover, the coexpression 
of both truncated cadherins had additive perturbation 
effects on neural development. The two truncated 
cadherins can interact with the three known catenins, 
but with distinct affinities.  These results suggest that 
the adhesive signal mediated by cadherins can be per- 
turbed by overexpressing their cytoplasmic domains 
by competing with different affinity with catenins 
and/or a common anchor structure.  Therefore, the 
correct regulation of cadherin function through the 
cytoplasmic domain appears to be a crucial step in 
the formation of the neural tissue. 
T 
HE development of multicellular  organisms proceeds 
by successive waves of cell  proliferation,  cell  mi- 
gration,  and cell condensation leading to extensive tis- 
sue rearrangements.  The interactions  of cells with their en- 
vironment play crucial  roles during  these processes, and 
acquisition of selective adhesive properties are assumed to 
be required to achieve the correct development of embryon- 
ic tissues (Edelman, 1992; Takeichi, 1991). Cell-cell adhe- 
sion is mediated by several classes of molecules including 
those belonging to the immunoglobulin  superfamily (Edel- 
man et al.,  1990; Springer,  1990) and the cadherin family 
(Geiger and Ayalon,  1992; Kemler et al.,  1989; Takeichi, 
1990). Cadherins are calcium-dependent cell surface glyco- 
proteins  with more than  15  members that  share high  se- 
quence similarity  (Koch et al.,  1992; Magee and Buxton, 
1991; Suzuki et al.,  1991). The amino-terminal  part of the 
extracellular domain of cadherins binds homotypically and 
links  together adjacent cells expressing the same type of 
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cadherin  (Nose et al.,  1990; Ozawa et al.,  1991).  The in- 
tracellular  domain binds to catenins  that may contribute to 
the  anchorage  of cadherins  to  the  cytoskeletal  network 
(Hirano et al.,  1992;  Kemler,  1993;  Magee and Buxton, 
1991; McCrea and Gumbiner, 1991; Nagafuchi et al., 1991; 
Ozawa et  al.,  1989,  1990a;  Ozawa  and  Kemler,  1992; 
Schwartz et al., 1990; Troyanovsky et al., 1993). Mutations 
in the calcium-binding  sites or deletions of part of the ex- 
tracellular  or cytoplasmic domain of cadherins  result in a 
complete loss of adhesive function.  In the latter  case, the 
truncated cadherins  are unable to bind to catenins and to an- 
chor to the cytoskeleton (Ozawa et al.,  1990b; Nagafuchi 
and Takeichi,  1988). 
In vivo,  the correlation  between the spatiotemporal  ex- 
pression of some cadherins  and morphogenetic events has 
been heavily documented in different species.  For instance 
in chicken and mouse embryos, differential expression of N-, 
E- (L-cellular adhesion  molecule [CAM] t,  P-,  R-, B-,  M- 
and T-cadherins has been associated with cell migration,  tis- 
sue segregation,  and terminal  differentiation  during  histo- 
genesis (Donalies  et al.,  1991; Duband et al.,  1987; Hatta 
1.  Abbreviations  used in  this paper:  CAM, cellular  adhesion molecule; 
NAM, normal amphibian medium; VSVG, vesicular stomatitis virus gly- 
coprotein;  X-gal, 5-bromo-4-chloro-3-indolyl-/3-o-galactopyranoside. 
© The Rockefeller University Press, 0021-9525/94/10/521/15 $2.00 
The Journal of Cell Biology, Volume 127, Number 2, October 1994 521-535  521 et al., 1987; Inuzuka et al., 1991; Moore and Walsh, 1993; 
Napolitano et al.,  1991; Nose et al.,  1987; Ranscht and 
Dours-Zimmermann, 1991; Sacrist,hn et al., 1993; Thiery et 
al., 1984). In vitro models have also provided some evidence 
that the modification  of the repertoire of cadherins at the cell 
surface is strongly associated with changes in cell morphol- 
ogy and is capable of inducing cell sorting (Detrick et al., 
1990;  Edelman  et  al.,  1987; Friedlander  et  al.,  1989; 
Fujimori et al.,  1990;  Matsuzaki et al.,  1990;  Nose et al., 
1988).  Thus, a well-defined expression pattern of cadherins 
confers selective adhesive properties that may, in turn, act 
as a regulator of morphogenetic processes. 
Recent studies have shown that a truncated form of cadhe- 
rin, deleted in its extracellular or cytoplasmic domain, could 
act as a dominant-negative mutant (Fujimori and Takeichi, 
1993; Kintner, 1992; Troyanovsky  et al., 1993; Levine et al., 
1994). This inhibition of the adhesive function of cadherins 
might involve a  competition between the cytoplasmic do- 
mains of the deleted cadherins and the endogenous ones, ei- 
ther for the binding of the catenins or other cytoplasmic 
components (Kintner, 1992) or for the occupancy of the nat- 
ural sites of expression of cadherins (Fujimori and Takeichi, 
1993).  A truncated form of E-cadherin deleted in the cyto- 
plasmic domain can induce a selective disruption of cadherin 
function (Levine et al.,  1994). 
In X_enopus laevis embryos, one of the earliest cadherins 
detected is the maternally derived EP-cadherin, which is ex- 
pressed at the cell surface during cleavage stages (Ginsberg 
et  al.,  1991; Levi  et  al.,  1991a).  XB-cadherin,  another 
closely related  cadherin and  U-cadherin  (Angres  et  al., 
1991; Herzberg et al.,  1991) were also reported to display 
a similar initial expression pattern. When tissue segregation 
begins to take place at the end of gastrulation, E-cadherin 
becomes expressed in the ectoderm (Choi and Gumbiner, 
1989; Levi et al., 1991b), and N-cadherin appears in the neu- 
roepithelium and the axial mesoderm (Detrick et al., 1990; 
Simonneau et al.,  1992). 
In the present study, we have analyzed the role of the XB- 
and N-cadherins during Xenopus laevis neurogenesis. We 
have  generated truncated constructs  for  these  cadherins, 
deleted  in  their  extracellular  domain,  which  can  act  as 
dominant-negative mutants. To target their expression to the 
prospective anterior neural territory, we have injected the 
corresponding mRNA into the four animal dorsal blasto- 
meres of 32-ceU stage embryos. The perturbation of both 
cadherins, which are expressed either before (XB-cadherin) 
or as a result of neural induction (N-cadherin), should give 
us some clues about the function of these molecules in the 
events that precede and follow neural tissue specification. 
We found that the expression of similar amounts of the trun- 
cated XB- or N-cadherin gives rise to different grades of de- 
velopmental defects in anterior neural structures. When both 
mRNAs were coinjected, additive effects were clearly ob- 
served. These distinct perturbation effects on embryonic de- 
velopment resulting from the alteration of endogenous cad- 
herin-mediated  cell  adhesion  could  reflect  the  different 
affinity properties of cadherin cytoplasmic domain for cate- 
nins. Therefore, in addition to the cadherin-mediated selec- 
tive homophilic interaction expressed during embryonic de- 
velopment,  the  affinity of specific  cadherin  cytoplasmic 
domain for intracellular ligands should also regulate cell 
adhesion. These results highlight the relative importance of 
specific cadherin-mediated cell adhesion in the early and late 
events that control neural tissue formation in Xenopus laevis. 
Materials and Methods 
Animals 
Adult Xenopus  laevis were obtained from the ~Service d'~levage de X~nope  v 
of the Centre National de la Recherche Scientifique (Montpellier, France). 
Mature oocytes were stripped from females injected 12 h earlier with 1,000 
IU of chorionic gonadotropin (Sigma Immunochemicals, St. Louis, MO) 
and immediately fertilized with a minced testis. Embryos were reared in 
normal amphibian medium (NAM) 0.1×  (Slack, 1985) and staged accord- 
ing to Nieuwkoop and Faber (1967). 
Generation of Truncated XB-Cadherin, N-Cadherin 
and N-CAM 
All the constructs used for in vitro transcription were inserted into pSP35T 
(Amaya et al., 1991), a modified version of the pSP64T vector containing 
the 5' and 3' untranslated sequences of Xenopus/3-globin gene (Krieg and 
Melton, 1984). 
We have previously isolated two full-length eDNA that represent the two 
allelic forms of Xenopus N-cadherin, called pBSSNcad and pBS9Ncad, 
respectively (Simonnea  u et al.,  1992).  The deleted N-cadherin construct 
was generated from pBS8Ncad. This modified eDNA codes for a N-cad- 
herin deleted in its extracellular region from amino acid (aa) 31 to aa 699 
(aa numbers refer 1o the immature protein). 
In a first step, pBSSNcad was digested by BspMI and Sinai, the cohesive 
ends generated by BspMI were filled, and all termini were dephosphory- 
lated. The 4.2-kb fragment containing the coding sequence from aa 699 to 
the carboxy terminus of the N-cadherin, 810 bp of 3' untranslated sequence 
and vector sequence, was purified from an agarose gel. In a second step, 
pBSSNcad was digested by PvuII-AvaI,  the cohesive ends were filled, and 
the 97-bp fragment was purified from an agarose gel. This fragment con- 
tains  12 bp of 5' untranslated sequence, the eDNA region coding for the 
signal peptide, and 4 aa of the propeptlde of N-cadherin. Both fragments 
were subsequently ligated, generating the N-cadherin-deleted eDNA con- 
struct called p8ANcad, which codes for the truncated N-cadherin. Ncol and 
Sail sites were created before the start codon and after the stop codon of 
the truncated cadherin eDNA by a PCR using specific oligonucleotides. The 
PCR insert was primed using an oligonucleotide carrying an NcoI restric- 
tion site at the 5' ~nd of the aminoterminal MGRKE aa sequence of the 
Xenopus N-cadherin (5'-TGCACCATGGGCCGAAAGAGC-Y)  and an an- 
tisense oligonucleotide containing a SalI site at the 3' end of the Xenopus 
N-cadherin carboxyterminal  YGGSDD  aa  sequence (5'-CACTGI1CGA- 
CTCAGTCGTCGCTCCCTCCGT-33.  The NcoI-Sall amplified fragment 
(912 bp) was subsequently inserted into the NcoI-SalI sites of the transcrip- 
tion vector pSP35T (a generous gift from Dr. M. Kirschner, Department 
of Biochemistry and Biophysics, University of California, San Francisco, 
CA). This construct called pANcad was subsequently used as a matrix to 
generate other deleted constructs. 
A hybrid eDNA was generated where the cytoplasmic coding sequences 
of Xenopus N-cadherin were substituted for those of Xenopus XB-cadherin 
(Herzberg et al., 1991). Synthetic oligonucleotides were made, the first cod- 
ing for the Xenopus XB-cadherin cytoplasmic IVVKEPL aa sequence and 
containing an in-frame SspI site at its 5' end (5'-GCGACCAATATTGTT- 
GTGAAAGAGCCACTA-3~.  The second is the complementary nucleotide 
sequence of the carboxy terminal DDDDEE aa sequence of Xenopus XB- 
cadherin with a SalI site at its 3' end (5'-ACGCCACGTCGACTACTCTTC- 
ATCATCATCA-3).  Both oligonucleotides were used for a PCR amplifica- 
tion of  the XB-cadherin eDNA. The resulting SspI-SalI-digested  primed in- 
sert (471 bp) was exchanged with the SspI-SalI insert of  pANcad, generating 
a  hybrid-deleted eDNA.  This  construct,  called  pANXBcad,  codes  for 
Xenopus-deleted N-cadherin aa sequence from aa 1 to aa 30 and aa 699 to 
aa 769, linked to the XB-cadherin cytoplasmic aa sequence between aa 303 
and aa 446 (aa numbers are according to the XB-cadherin sequence pub- 
lished by Herzberg et al.,  1991). 
Another construct was generated that codes for an N-cadherin/N-CAM 
hybrid protein. The N-CAM sequence coding for the transmembrane and 
cytoplasmic domains of  the 140-kD mol mass spliced form were juxtaposed 
to the 41 amino-terminal aa of  the pANcad sequence by the following proce- 
dure: the DNA fragment of the Xenopus N-CAM 140 sequence, encoding 
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ing the exon 18 sequence, was produced by PCR amplification using specific 
oligonucleotides of a  Xenopus liver eDNA library prepared from adult 
Xenopus liver. Briefly, liver RNAs were prepared from adult Xenopus laevis 
using the guanidinium-phenol-chloroform method (Chomczynski and Sac- 
chi, 1987) and eDNA synthesis was carried out using a eDNA synthesis kit 
(Boehringer Mannheim Biochemicals, Indianapolis, IN) from 2/zg of poly 
A + mRNAs prepared with the mRNA preparation kit  (Pharmacia Fine 
Chemicals, Piscataway,  NJ). The N-CAM 140 fragment obtained by PCR 
was primed at the 5' end with an oligonucleotide containing a PstI site in 
frame with the GLGTGA aa sequence of the Xenopus N-CAM (5'-CGG- 
ATCCTGCAGCGGTTTGGGAACAGGAGCA-Y), and at the 3' end with an 
oligonucleotide containing a Sail site and the NESKA aa sequence of the 
Xenopus N-CAM (5"CTTGAGCGTCGACTCATGCTTTC~TCTCATT-3). 
These oligonucleotide sequences were chosen according to the Xenopus 
N-CAM coding sequence previously published (Krieg et al.,  1989).  This 
insert (558 bp) was digested with both restriction enzymes and subsequently 
introduced into the SalI and XbaI sites of pANcad (the Sail site was 121 
pb far from the start codon and the XbaI site was located just after the stop 
codon of pANcad). This construct was called pANcadNCAM. 
All the constructs were subsequently checked by sequence analysis using 
the Sequenase  TM  kit (Amersham Corp., Arlington Heights, IL). 
Introduction of an Epitope "Tag"  into the 
Truncated Constructs 
To detect the truncated proteins expressed after injection into blastomeres, 
we introduced into the coding sequences of the truncated proteins, a "tag" 
sequence coding for the YTDIEMNRLGK aa sequence of the carboxy- 
terminal tail of the vesicular stomatitis virus glycoprotein (VSVG) that can 
be specifically recognized by monoclonal antibody P5IM (Kreis,  1986). 
This epitope, designated VSVG-11, has been juxtaposed to a hinge sequence 
coding for GPPGP at its amino-terminal extremity to improve its accessibil- 
ity in the protein; the resulting GPPGPYTDIEMNRLGK aa sequence is 
called VSVG-16. The KS-pCV6-Nter-VSVG plasmid (a generous gift from 
Dr. B. Good, Institut Pasteur, Paris, France) was used as a matrix to amplify 
the VSVG-16 coding sequence by PCR and to create an in-frame PstI restric- 
tion site at its 5' and 3' ends. The insert was primed with an oligonucleotide 
coding for GPPGPY aa sequence of VSVG-16 epitope with an in-frame PstI 
site at its 5' end (5'-CATACCTGCAGI"GGCCCACCAGCd2CCATAC-Y)  and 
an oligonucleotide coding for the complementary MNRLGK aa sequence 
of the VSVG-16 epitope with an in-frame PstI site at its 3' end (5'-TTAGCG- 
TCGACTTGCCCAC,-CCGGTTCATCT-3).  This insert (73 bp) was subse- 
quently digested with PstI restriction enzyme and introduced into the PstI 
site into the extracellular coding sequence of the truncated cadherin coding 
sequence. The constructs were subsequently checked by sequence analysis. 
The VSVG-16  epitope insertion into the constructs is indicated in Fig. 
1, A-C. 
In Vitro Transcription of the Truncated Constructs 
For in vitro transcription, all constructs were linearized at the end of the 
T-untranslated Xenopus/3-globin sequence and transcribed using SP6 poly- 
merase according to Melton et al.  (1984).  Control mRNA was obtained 
from pSP64T vector coding for/3-galactosidase (a generous gift from Dr. 
C. Kintner, Salk Institute for Biological Sciences, San Diego, CA; Derrick 
et al., 1990).  mRNA transcribed in vitro by SP6 polymerase were checked 
with a rabbit reticulocyte lysate translation assay (Amersham Corp.). 
Embryo Injections 
Embryos were dejeUied at the two-cell stage in 2% cysteine (pH 7.8) and 
immediately transferred at 16°C into NAM 0.1 x  plus 5 % Ficoll containing 
penicillin and streptomycin until they reached the 32-cell stage. The four 
animal dorsal blastomeres were injected with 2-5 nl of mRNA using an Ep- 
pendorf pressure-driven microinjector (i.e., 0.025-1.25  ng of mRNA per 
blastomere). Dorsal blastomeres were identified according to the criteria 
of pigmentation and size (Fig. 3  C) described by Nieuwkoop and Faber 
(1967).  After injection, the embryos were maintained in the NAM/Ficoll 
solution for 15 h at 23"C and were thereafter transferred into NAM 0.1× 
solution for further development. 
In Vivo Translational  E~ciency of Truncated mRNA 
12 Xenopus embryos at the two-cell stage were injected with pANXBcad, 
pANcad, or pANcadNCAM mRNA (6.25  ng) and 0.3 #Ci of 35S-Trans- 
label (ICN Biomedical, Inc., Costa Mesa, CA). Each batch of 12 embryos 
reaching stage 13NF were homogenized in 600 #1 of cooled immunoprecip- 
itation buffer (100 mM NaC1,  10 mM Tris, pH 7.5, 2 mM CaC12, 1% Tri- 
ton X-100,  1% NP-40, 0.1% SDS, and protease inhibitor cocktail); the ho- 
mogenate was centrifuged for 10 rain at 10,000 rpm in a microfuge to clear 
the extract of  yolk and lipids. The clarified supernatants were incubated un- 
der agitation with the P5IM monoclonal antibody for 2 h at 4°C. The ex- 
tracts were then incubated with 100 #1 of  protein G-plus-agarose beads (On- 
cogene Sciences, Paris, France) for 1 h, and the beads were subsequently 
separated by low speed centrifugation. After five washes in the immunopre- 
cipitation buffer, the beads were boiled for 10 rain in 100 td of Laemmli 
sample buffer and were then removed by centrifogation. The immunopre- 
cipitated proteins were fractionated on a 12 % SDS-polyacrytamide  gel. The 
gel was subsequently fixed, incubated with amplify solution (Amersham 
Corp.), dried, and autoradiographed. The autoradiography was digitalized 
using a video camera (612F; Data Copy) linked to an acquisition module 
and a graphic control unit that was designed by the staff of the Computer 
Science Laboratory of the Ecole Normale Sup6rieure. A band profile was 
obtained for each truncated protein made in the translational assay. These 
profiles were subsequently analyzed using the HERMES software (Vincent 
et al.,  1986) to quantify the intensity of each band (arbitrary units). 
Coprecipitation of Catenins by Truncated Cadherins 
12 Xenopus embryos at the two-cell stage were injected with pANXBcad 
or pANcad mRNA and 35S-Trans-label as previously described. Each batch 
of 12 embryos reaching stage 13NF were homogenized in 600 #1 of SDS- 
free immunoprecipitation buffer (100 mM NaPO4, pH 7.2, 2 mM CaCI2, 
1% Triton X-100, 1% NP-40, and protease inhibitor cocktail). After carry- 
ing the same immunoprecipitation procedure that was used to check mRNA 
translation efficiency,  the catenins that coprecipitated with the truncated 
cadherins were identified on a 7.5 % SDS-polyacrylamide gel. The autoradi- 
ography was scanned as previously described. 
Detection of  ~-Galactosidase Activity 
Embryos  were  processed  for  X-gal  (5-bromo-4-chloro-3-indolyl-/~-o- 
galactopyranoside) staining as described in Derrick et al. (1990).  Briefly, 
the embryos were fixed in 2% paraformaldehyde (PFA) and 2% glutaralde- 
hyde in PBS for 1 h on ice. After two rinses in PBS, embryos were incubated 
in  10 mM K4Fe(CN)6,  10 mM K3Fe(CN)6,  1 mM MgC12, 0.1%  Triton 
X-100, 0.15%  X-gal (Sigma Immunochemicals) in PBS overnight at 37"C. 
Subsequently, the embryos were dehydrated, depigmented for 2 h in 70% 
methanol,  10%  H2(h,  and  clarified in benzyl  alcohol/benzyl benzoate 
(1 vol/2 vol) for 15 rain. The embryos were photographed and then trans- 
ferred twice for 15 rain in xylene, embedded in paraplast, and sectioned 
as described by Levi et al.  (1987). 
Antibodies 
A  rabbit polyclonal antibody made against Xenopus N-CAM was kindly 
provided by Dr. Gerald Edelman (Scripps Clinic, La Jolla, CA; Levi et al., 
1990).  Monoclonal antibodies 12/101 specific for skeletal muscle (Kintner 
and Brockes, 1985) and 4D specific for N-CAM 180 kD (Watanabe et al., 
1986) were purchased from the Developmental Studies Hybridoma Bank 
maintained by the Department of Pharmacology and Molecular Sciences, 
Johns Hopkins University School of Medicine (Baltimore, MD), and the 
Department of Biological Sciences, University of Iowa (Iowa City, IA), un- 
der contract N01-HD-6-2915  from the National Institute of Child Health 
and Human Development. The P5D4 monoclonal antibody, directed against 
the carboxy terminus of the vesicular stomatitis virus glycoprotein (Kreis, 
1986),  was a gift from Dr. B. Goud and was used to detect the "tag" se- 
quence of the truncated proteins. The anti-rabbit-Ig antibody conjugated to 
fluorescein or peroxidase and the anti-mouse-Ig antibody conjugated to 
rhodamine or peroxidase were purchased from Amersham Corp. 
Immunodetection 
Embryos were fixed in isopemane, cooled in liquid nitrogen as described 
in Levi et al. (1987),  embedded in paraplast, and 7.5-/~m sections were pre- 
pared. The immunohistochemistry was performed as described by Saint- 
Jeannet et al.  (1992).  For whole-mount immunocytocbemistry, viteUine 
membrane-free embryos were fixed for 2 h in 20% DMSO/80% methanol, 
transferred into 10% (final concentration) hydrogen peroxide diluted in the 
fixative,  and incubated at room temperature for 2 d. After bleaching, the 
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muscle antigens expressed  by the embryos were revealed using the 12/101 
monoclonal antibody followed by an incubation with an anti-mouse Ig con- 
jugated to the horseradish peroxidase.  After detection of the peroxidase ac- 
tivity,  the embryos were observed and subsequently  treated with the 4D 
antibody specific for Xenopus N-CAM followed by horseradish-peroxidase- 
coupled anti-mouse Ig. 
Histological Staining 
The embryos were fixed for 1 h in PFA 2 % plus glutaraldehyde  2 % in PBS. 
After two rinses in PBS and one in water, the embryos were dehydrated and 
embedded in paraplast as described in Levi et al. (1987). 5-#m paraplast 
sections were collected on gelatin-coated glass slides, deparaflinized  in xy- 
1erie, and rehydrated.  Sections were then stained using the Ramon y C~j~ 
tfichrome according to Gabe (1968).  Briefly, sections were incubated 10 
rain in Zielh's fuschin (1/10; vol/vol), rinsed for 5 min in water, then washed 
for 1 rain in 0.4% acetic acid before 10 min incubation in 0.4%  indigocar- 
rain prepared in picfic acid-saturated water.  After 2 min dehydration in 
100% ethanol, the sections were transferred to xylene and mounted in Eu- 
kitt mounting medium (Prolabo,  Fontenay-sous-Bois,  France). 
Quantification of Cell-CeU Disruption 
To determine the sequence of events that lead to cell dissociation after injec- 
tion of truncated cadherin mRNA,  the embryos were micro-cinemato- 
graphed using a time-lapse video apparatus (Mitsubishi video tape recorder 
6720; Mitsubishi Kasei  Corp.,  Tokyo) connected to a binocular (Nikon 
Inc., Melville, NY) through a Panasonic color camera (WV-CD130L; Mat- 
sushita Electric Industrial Co., Ltd., Osaka, Japan). Videos were then ana- 
lyzed  on a  Panasonic color monitor (M1400;  Matsushita Electric Co., 
Ltd.). Cell-cell disruption was quantified at the neurula stage (stage 15-17) 
by estimating the number  of cells expelled from the embryos. A low number 
of cells released (In) referred to an approximate  loss of several tens of cells; 
a high number of cells released (hn) referred to several hundreds of cells 
released from the embryos. 
Quantification of Retinal Mass in Control 
and Injected Embryos 
Serial sections of control or injected embryos showing either perturbations 
in their retinal layers or fused retina were observed at a magm'fication of 
200 using a video camera fixed on a binocular system (SMZ-U zoom; Nikon 
Inc., Melville, NY) and connected to a TV monitor.  Retinal areas observed 
on each section were manually plotted on the TV monitor screen and copied 
onto a transparent paper. The transparent paper area drawings that exactly 
corresponded to the retinal areas for each embryo analyzed were weighed, 
thus giving arbitrary units to determine the retinal  mass values. 
Results 
pA  Ncad, pANXBcad, and pANcadNCAM 
cDNA Constructs and In Vivo  Assay  for the mRNA 
Translational EjOiciency 
A portion of the extracellular domain of the Xenopus N-cad- 
herin pBS8Ncad  sequence  (Simonneau  et  al.,  1992)  was 
deleted to generate a eDNA coding for an N-cadherin trun- 
cated between aa 31 in the propeptide sequence and aa 699 
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Figure 1.  Schematic  representation  of the  truncated  NXB-,  and  N-cadherin,  and  NcadNCAM  hybrid.  (,4)  The  truncated Xenopus 
N-cadherin/N-CAM hybrid protein is encoded by the pANcadNCAM mRNA and contains N-CAM transmembrane and cytoplasmic do- 
mains of the 140-kD mol mass spliced variant form juxtaposed to the 40 aminoterminal aa of the pANcad sequence (B) The truncated 
Xenopus N-cadherin protein is deleted in its extracellular region from aa 31 to aa 698, and it is encoded by the pANcad mRNA.  (C) The 
truncated Xenopus N-cadherin/XB-cadherin hybrid protein contains N-cadherin aa sequences from aa 1 to aa 30 and aa 699 to aa 769 
linked to the XB-cadherin aa sequences between aa 303 and aa 446. The tag VSVG-16 epitope is localized between aa 40 and 41 of the 
extracellular domain of all the truncated constructs.  TM, transmembrane domain; EC, extracellular domain; sig, signal peptide; pre, 
propeptide sequence; VSVG-16, vesicular stomatitis virus glycoprotein carboxyterminal epitope recognized by a specific P5D4 monoclonal 
antibody and used as a  tag for immunocytoehemistry and whole-mount immunostaining. 
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between aa number 40 and 41 of the extracellular truncated 
domain.  The  transmembrane  and  cytoplasmic  sequences 
were unchanged. This pANcad construct codes for the trun- 
cated N-cadherin and contains 253 aa (Fig.  1 B). This con- 
struct was then used to generate deleted constructs for XB- 
cadherin and N-CAM.  An N-cadherin/XB-cadherin hybrid 
eDNA was obtained by exchanging the cytoplasmic coding 
sequence of N-cadherin with that of XB-eadherin. Both con- 
structs contained the truncated extracellular domain with the 
tag epitope, the transmembrane domain, and the first 24 aa 
of the cytoplasmic domain of N-cadherin. The pANXBcad 
construct codes for an N-cadherin/XB-cadherin hybrid pro- 
tein of 266 aa (Fig.  1 C). 
A control construct was generated that codes for a trun- 
cated N-cadherin/N-CAM hybrid protein containing 197 aa 
(Fig.  1  A;  pANcadNCAM).  It  contained the  40  amino- 
terminal aa of  the truncated N-cadherin juxtaposed to the tag 
epitope and the Xenopus N-CAM sequences from the last 6 
aa of the extracellular domain to the carboxy terminus. This 
hybrid codes for the 140-kD spliced cytoplasmic domain of 
Xenopus N-CAM. 
All these deleted constructs were linearized at the end of 
the  3' untranslated  Xenopus  /~-globin  sequence  and  tran- 
scribed using SP6 polymerase as described by Melton et ai. 
(1984). 
The translational efficiency of each mRNA was tested in 
vivo by  coinjecting them  with  35S-Trans-label  in  two-cell 
stage embryos. Extracts prepared from stage 13NF embryos 
were subjected to immunoprecipitation with anti-tag mono- 
clonal antibody. Fig. 2  shows the immunoprecipitated pro- 
teins analyzed on 12% SDS-polyacrylamide gels. The trun- 
cated NCadNCAM hybrid has an apparent molecular mass 
of 30 kD (lane a), two bands of 21 and 22.1 kD are obtained 
for truncated N-cadherin (lane b), two bands of 24.5 and 
27.4  kD  are  also  observed  in  the  case  of  truncated 
pANXBcad mRNA injection (lane c). The upper band ob- 
served in lanes b and c could correspond to a form of trun- 
cated cadherins still carrying the signal peptide. The autora- 
diography  was  subsequently  scanned  and  the  intensity 
calculated (arbitrary units) for each band. An intensity of  25 
was found for the truncated NCadNCAM hybrid. The inten- 
sity was,  respectively, 133 and 51  for the lower and upper 
band corresponding to the truncated N-cadherin,  while it 
was,  respectively,  83  and  65  for  the  truncated  NXB- 
cadherin.  Taking  into  account the  fact that the truncated 
NCadNCAM  hybrid contained one methionine instead of 
five for the truncated cadherins, these results indicate that all 
the mRNA  constructs have a  similar in vivo translational 
efficiency. 
Fate Map of  Injected Blastomeres 
The four animal-dorsai blastomeres (4-AD) of 32-cell stage 
embryos, referred to as blastomeres A1 A2 and their A'I A'2 
counterparts across the midline (Dale and Slack, 1987) have 
been shown in several fate map studies to contribute mainly 
to  the  anterior  neural  structures  of the  embryo  (Moody, 
1987;  Dale and Slack,  1987;  Jacobson and Hirose,  1981). 
Therefore, to target the presumptive neural blastomeres, the 
4-AD blastomeres were chosen as the site of injection (Fig. 
3 C, arrowheads). 
In a first set of experiments, the 4-AD blastomeres were 
Figure 2. In vivo translation ability of mRNA coding for truncated 
cadherins or truncated  N-cadherin/N-CAM  hybrid.  The mRNA 
were coinjected with 35S-trans-label mixture at the two-cell stage 
of Xenopus embryos.  At  stage  13-13.5NF, the  embryos  were 
homogenized in immunoprecipitation buffer and incubated with 
anti-VSVG monoclonal antibody P5D4. The radiolabeled proteins 
immunoprecipitated were loaded on 12% acrylamide gel and re- 
vealed by autoradiography. Lane a, truncated NcadNCAM hybrid; 
lane b,  truncated  N-cadherin;  lane  c, truncated  NXB-cadherin. 
Low molecular mass markers electrophoretic mobility are indi- 
cated on the left. 
injected with mRNA encoding/3-galactosidase to test the in- 
jection procedure and check for the progeny of the injected 
blastomeres. 
At stages  23-26,  the injected embryos were fixed, pro- 
cessed  for an  X-gal  staining,  and  photographed.  As  ex- 
pected, the anterior structures such as the cement gland, the 
optic cups, and the proencephalon expressed strong/~-galac- 
tosidase activity without any apparent defect in their organi- 
zation (Fig. 3, A and B). The diencephaion, the anterior ec- 
toderm, and the head mesenchyme were stained to a lesser 
extent. Occasionally, a faint staining could also be observed 
in the notochord and in few somitic cells. The embryos were 
subsequently embedded in paraffin and sectioned. Labeled 
/$-galactoside-positive cells  were found in  well-organized 
neuroepithelia of the eye cup and the brain, as well as in the 
cement gland (Fig. 3 D). These results are consistent with 
the previously published fate maps for the 32-cell stage of 
Xenopus laevis. 
Injection of mRNA Encoding the Truncated Cadherins 
Induce Developmental Defects 
Embryos injected at the 32-cell stage were examined at stage 
32NE They were fixed and analyzed by a sequential whole- 
mount immunostaining with anti-skeletal muscle monoclo- 
nal antibody and then with anti-N-CAM monoclonal anti- 
body.  The results of each immunostaining  were observed 
separately and the double whole-mount immunostaining is 
shown on Fig. 4, A-E. Embryos injected with pANXBcad 
mRNA exhibit extended malformations of the anterior neu- 
ral structures as  revealed with the anti-N-CAM  antibody. 
The emergence of  cranial nerves is delayed, the development 
of the eye is abnormal and delayed and numerous N-CAM- 
positive cell clusters are observed on each side of the mesen- 
cephalon (Fig. 4, arrows in A and arrowheads in B) in con- 
trast to control embryos (Fig. 4, D, arrows,  and E).  The 
posterior structures and somites did not appear to be affected 
as revealed with the 12/101 antibody. At stage 41NF, the mor- 
phological appearance of injected embryos showed signifi- 
cant defects in eye development and in structures such as the 
cement gland and the anterior nervous system (Fig. 4 C, ar- 
rows) as compared to the control embryo (Fig. 4 F). Whole- 
mount  immunostaining  was  also  performed  on  injected 
embryos at stage 43NF with 4D and 12/101 monoclonal anti- 
Dufour et al. Altered  Morphogenesis Induced by Truncated Cadherins  525 Figure 3.  Fate map of the four animal dorsal blastomeres  injected at the 32-cell stage.  (.4) Lateral  view of embryos injected with 0.25 
ng of/3-galactosidase mRNA (Ix concentration) at the 32-cell stage and processed for X-gal staining at stage 25NF. X-gal activity is re- 
stricted to the anterior  neural structures.  Staining in the endodermal mass is artefactual.  (B) In the inset, a dorsal anterior  view of an 
injected embryo where X-gal staining is localized to the optic vesicles, the brain, the cement gland, and to a lesser extent in the ectoderm 
and head mesenchyme. (C) Injection sites on a 32-cell stage Xenopus embryo. The four animal dorsal blastomeres  (4-AD) A1, A2 (Dale 
and Slack, 1987) and their A'I, A'2 counterparts across the midline (arrowheads) were the target blastomeres. They are less pigmented and 
smaller in size than blastomeres of the ventral side. (D) Embryos injected with ~-gaiactosidase mRNAs are processed for X-gal staining 
before sectioning at stage 25NE Cells expressing the B-galactosidase activity are restricted to the neural lineage and the cement gland. 
Bar, 260 gm in A, 200 gm in B, 400 #m in C, and  106 gm in D. 
bodies. The embryos injected with pANXBcad mRNA pos- 
sessed numerous differentiated neuronal aggregates or single 
neurons with long processes localized under the ectoderm. 
An abnormal and extensive fasciculation of nerves emerging 
from the cranial ganglia was found. Some defects in the head 
skeletal muscles and hyperplasia of neural structures were 
also observed (data not shown). 
Quantification of the perturbations obtained after mRNA 
injections  was  performed  at  stage  41NF.  Increased  con- 
centrations of injected pANXBcad and pANcad mRNAs re- 
suited  in  an  increase  in  the  percentage  of embryos with 
aberrant  morphology  (Fig.  5  A).  At  a  low  concentration 
(0.1 × ), pANXBcad mRNA induced more malformations than 
pANcad mRNA:  17.7 % of the embryos had developmental 
defects (n =  17) in the case of the pANXBcad mRNA injec- 
tions, while no malformations were detected in the case of 
pANcad mRNA (n  =  13)  or pANcadNCAM mRNA (n  = 
12) injections. An increase in the amount of pANcad mRNA 
injected induced developmental defects in 20% (n =  30) and 
34.8%  (n  =  23) of the cases examined for the  Ix  and 5x 
concentrations, respectively, whereas pANXBcad mRNA at 
1x  and  5×  concentrations  resulted  in  high  numbers  of 
embryos with  malformations:  63%  (n  =  38)  and  72.3% 
(n  =  18),  respectively. Injection of control pANcadNCAM 
mRNA at 1× and 5 ×  concentrations induced malformations 
at only low frequency in 9%  (n  =  12) and'16%  (n  =  25), 
respectively, of injected embryos. 
To analyze this differential effect on developmental abnor- 
malities produced by pANXBcad or pANcad mRNA injec- 
tions,  we  performed  coinjection  of  both  mRNA.  Each 
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by  injection  of  pANXBcad 
mRNAs  at  1×  concentration. 
Whole-mount immunostaining of 
an injected (A and B) and control 
(D and  E)  embryo at the  stage 
32NF with the anti-N-CAM 4D 
monoclonal  antibody  and  the 
12/101  monoclonal  antibody 
directed  against skeletal muscle. 
A  and  D  are the  lateral  views, 
and B and E are the dorsal views. 
Numerous  N-CAM  positive cell 
clusters  are observed  (B, arrow- 
heads), as well as a delayed de- 
velopment  of eye and of cranial 
nerve emergence  (A, arrows) in 
the case of the injected embryos 
when compared to the control (D, 
arrows, and E). No defect in so- 
mitic  development  is  detectable 
at this  stage.  Morphology  of an 
injected (C) and control (F) em- 
bryo at stage 4 INE Abnormal de- 
velopment of anterior structure is 
visible  in C, which represents  a 
typical  injected  embryo.  The 
main defect  is  observed  on  the 
eye  development  (arrowheads). 
Bar, 290 #m in A, B, D, and E 
and 640/zm in C and E 
mRNA was used at a  concentration  (Ix) that gave rise to 
significant  developmental  defects,  but  that  did  not  cor- 
respond to the  maximum effect.  Two independent  experi- 
ments were performed where both pANXBcad and pANcad 
mRNA were coinjected each at a 1  x  concentration. Interest- 
ingly,  the  coinjection  of  both  pANXBcad  and  pANcad 
mRNA at this concentration produced developmental defects 
at very high frequency, 92.3 % (n  =  13) when compared to 
that of individual injection at a concentration of Ix or 5x. 
This result indicated that the truncated cadherin species had 
additive effects in generating developmental abnormalities. 
Grades of  Perturbations Induced by the Expression of 
Truncated Cadherins 
Injected embryos fixed at stage 41NF were sectioned, stained 
using the Ramon y Chjhl trichrome procedure, and analyzed 
to define grades of  perturbations. The nature of the perturba- 
tion  appeared  to  be  strongly  dependent  on  the  type  and 
amount of mRNA injected. In this study, we focused on the 
analysis  of pertubation  in  the  retina  because  even minor 
defects can be easily detected. Injected pANXBcad mRNA 
at 1  x  and 5 x  concentrations resulted in strong defects in the 
anterior nervous system characterized by incomplete optic 
cup morphogenesis (the cup most frequently remained fused 
to the floor of the diencephalon;  Fig.  6 G, arrowheads, J, 
and K), as well as disorganization in retinal cell layers (Fig. 
6, J, H, and I, arrows and arrowheads). 44.7% and 50% of 
the embryos analyzed presented this phenotype for lx  and 
5 ×  concentrations,  respectively (Fig.  5 B). 
When low amounts of pANXBcad mRNA (0.1x  concen- 
tration) or higher amounts of pANcad mRNA (ix  and 5x 
concentrations) were injected, the prominent abnormalities 
observed were a disorganization of the retinal layers; these 
defects were observed in  17.7%,  16.7%,  and  17.4%  of the 
embryos analyzed,  respectively (Fig.  5  B).  Defects in the 
morphogenesis of the optic cup were also visualized (0%, 
3.3 %, and 17.4%, respectively). For pANcadNCAM mRNA 
injections at the Ix and 5x concentrations, all the perturbed 
embryos (9%  (n  =  12) and  16%  (n  =  25) of injected em- 
bryos, respectively), presented only defects in the organiza- 
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Figure 5.  (A) Quantification of the perturbations 
obtained for the different truncated cadherins: the 
results are expressed in percent of embryos with 
malformations  for  increased  concentrations  of 
mRNA (0.1  x, 1 x, and 5 x  concentrations corre- 
sponding to 0.025, 0.25, and 1.25 ng of mRNA per 
blastomere,  respectively).  Increased  concentra- 
tions of mRNA induce more severe malformations 
in anterior structures. (B) Grades of perturbations 
induced by the injection of the different mRNA. 
The grades were scored by determining the per- 
cent of perturbed embryos showing a perturbed 
morphogenesis of the retina that remains fused to 
the central nervous system (lefipanel)  or a disor- 
ganization  in  the  retinal  layers  (right panel). 
pANXBcad mRNA at the 1  x  and 5 x  concentra- 
tions  primarily  induced  severe  developmental 
defects of anterior structures, with the retina re- 
maining attached to the floor of the diencephalon. 
In  contrast,  similar  concentrations  of pANcad 
mRNA induced mainly abnormalities in the orga- 
nization of the plexiform layers of the retina. Em- 
bryos injected with pANcadNCAM mRNA exhibit 
only perturbations in the organization of  the retinal 
layers. 
Figure 6. Ramon y C~jtd trichrome histological staining of stage 41NF embryos. Histologically stained section of a control embryo (A) 
showing, from left to right, the brain with an eye on each side and the pharynx. (D) Typical embryo showing perturbations in retinal 
cell layers (arrowhead). The mesencephalon and the pharynx have a normal morphology and localization, while the organization of the 
retinal layers are altered with additive photoreceptor and neuropil clusters clearly observed at higher magnification (E and F, arrowheads 
and arrows). (G, J, and K) Another type of perturbation observed after injections of mRNA coding for truncated NXB-cadherin at Ix 
or 5 x  or N-cadherin at 5 ×  concentration. Optic vesicles exhibit strong defects in their morphogenesis with retinas remaining fused to 
the ventral part of the brain (G, arrowheads). They either exhibit additive photoreceptor and neuropil clusters (J, arrowheads) or more 
drastic perturbations with delayed and aborted morphogenesis of the eye (K). Morphology of a control eye (B and C, at higher magnifica- 
tions). From left to right on B and from top to bottom on C, the pigmented retinal epithelium (pe), the outer segment of the photoreceptors 
(os), the nuclear layer (nl), the plexiform layer (pl), and the ganglion cell layer (gcl) can be identified. Higher magnifications of  a representa- 
tive retina showing perturbation in its cell layer organization (E and F). Note a neuropil clustering near the photoreceptor layer (arrow) 
and an additional photoreceptor cell clustering in the nuclear layer (arrowheads). Higher magnification of fused retinas (H, I, and L) 
showing also stronger alterations of the eye structure represented by multiple small retina arrangements composed of all cell layers that 
were juxtaposed into the same eye cup (H and/, neuropil layer, arrows; double-photoreceptor layer, arrowhead). Bar, 100 #m in A, D, 
G, J, and K, 23 tim in L, 20 #m in B, E and H, and 10 gm in C, F  and L  C and F are made with the Nomarski optical system. 
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inas, even for the 5 x  concentration pANcadNCAM mRNA 
injection. 
The perturbed retina often exhibited isolated plexiform 
layer clusters near the pigmented epithelium (Fig. 6 E, ar- 
rows), and groups of photoreceptor ceils inserted into the 
nuclear cell layer (Fig. 6, D-F, arrowheads). Section of the 
anterior portion of control embryos injected with/3-galacto- 
sidase mRNA was shown in Fig. 6 A, Corresponding retina 
at different magnifications was shown in Fig.  6, B and C. 
These structures never exhibited abnormalities in their devel- 
opment. In the case of embryos coinjected with pANXBcad 
and pANcad mRNA at the Ix concentration, we observed 
a fused or aborted retina in 84.6% of analyzed embryos, and 
only abnormalities  in  the retinal layers were observed in 
7.7 % of the embryos analyzed (data not shown). 
The retinal masses of control and perturbed embryos (ac- 
cording to the type of perturbation) were quantified at stage 
41NE In the case of control embryos, injected embryos ex- 
hibited perturbed retinal layers, or injected embryos showed 
a fused retina, the mean of retinal mass was 5.94 +  0.3, 6.25 
5:  1.2, and 3.90 +  1.8 (n =  8, arbitrary units), respectively. 
Control embryos represented a homogenous population con- 
cerning their retinal mass. A small increase of retinal mass 
was observed for embryos exhibiting abnormalities in their 
retina, which represented hyperplasia caused by additive cell 
layers such as photoreceptor layers or neuropil clusters, and 
was observed for other anterior structures later in the devel- 
opment of injected embryos. Embryos exhibiting fused ret- 
inas constituted a more heterogenous population that corre- 
sponded to distinct types of fusion. The first type showed a 
developmental timing and retinal mass values similar to the 
control eye or an eye presenting hyperplasia (Fig. 6, G and 
J). The second type, which exhibited mainly lower retinal 
mass,  corresponded to embryos presenting  a  delayed eye 
morphogenesis (Fig. 6 K). 
Early Morphogenetic Defects 
Injection of pANXBcad mRNA in the blastomeres A1 and 
A2 also lead to severe malformation in the eye cup of stage 
23NF embryos, as observed for injections into the four ani- 
mal dorsal blastomeres.  The descendants of these blasto- 
meres can be followed by coinjecting ~-galactosidase mRNA. 
Moderately labeled fl-galactosidase-positive cells are seen 
in the diencephalon, in the neural retina anlage, and in the 
cement gland; most of these cells do not have a radial organ- 
ization (Fig. 7 A, arrowheads). Heavily labeled cells are re- 
grouped in clusters outside the eye cup (Fig. 7 A, arrows). 
All  the  neuroepithelial  cells  and  the  clustered  cells  are 
N-CAM positive (Fig. 7 B, arrows). The truncated cadherin 
can be easily immunolabeled in the clustered cells by the 
anti-tag antibody (Fig.  7  C); however, the truncated cad- 
herin cannot be routinely detected by this method in the dis- 
organized neuroepithelial cells that express fl-galactosidase 
moderately. It is likely that the injected mRNA are not uni- 
formly distributed in all the progeny of the injected blas- 
tomeres and/or that the enzymatic activity is a more sensi- 
tive method than  immunolabeling in  this  particular case. 
pANcadNCAM mRNA injected in the same blastomeres did 
not induce any malformation; well-organized radial neuro- 
epithelial cells are immunolabeled with the anti-tag antibody 
(Fig. 7 D). 
Differential Alteration of  Adhesive Contacts 
at Early Stages 
To better understand the differential effect  of  the two different 
truncated N- and NXB-cadherins, we have searched for the 
earliest  detectable  pertubation  events.  After  injection  of 
pANcad and pANXBcad mRNA into the 4-AD blastomeres 
at the 32-cell stage, the first phenomenon observed was a re- 
lease of cells in the anterior part of the embryo at stage 13- 
13.5NF. This cell release was analyzed for embryos injected 
at the 32-cell stage with 0.25 ng of pANXBcad mRNA (Ix 
concentration) using a time-lapse video. At stage  12.5NF, 
some cells in the anterior part of the embryos started to pro- 
trude extensively in a limited area. This was followed by a 
spilling over of cells, apparently coming from the inner cell 
layer of the anterior ectoderm. Some pigmented cells from 
the outer cell layer of the embryo were also released at that 
time. The entire process of cell release, which lasted m45 
min, was initiated when the embryo was undergoing two con- 
tractions, as seen by video analysis. The cell release result- 
ing from the inhibition of cadherin mediated cell-cell adhe- 
sion caused by the truncated cadherin expression is a good 
indicator for reduced adhesive strength. However, the num- 
ber of  cells released (around several tens or hundreds of cells 
released) is small compared to the estimated number of cells 
originating  from  the  4-AD  blastomeres  at  stage  13NF 
(m3,000 cells). The results are presented in Table I; for iden- 
tical amounts of mRNA, the number of cells released was 
higher with pANXBcad than with pANcad. At a 5 x  concen- 
tration,  52.8%  of the pANXBcad embryos and  14.8%  of 
pANcad  embryos  exhibited  an  "hn"  phenotype  (several 
hundreds of cells expelled) and 30.5 % and 3.7 % for the "In" 
phenotype (several tens of cells expelled). At the intermedi- 
ate  mRNA  concentration (Ix),  similar  differences in  the 
ability of two mRNA species to produce hn and In pheno- 
types were observed.  In  contrast,  at lower concentration 
(0.1x),  neither  pANXBcad  nor  pANcad  induced  the  hn 
phenotype, and both promoted identical low levels of In em- 
bryos (5.9% and 4%). Cell release was never observed when 
control pANcadNCAM mRNA was injected, even at the 5 × 
concentration. 
Truncated Cadherin-Catenin Interactions 
To check the ability of our truncated cadherin to interact 
with catenins,  we performed immunoprecipitation experi- 
ments using the P5D4 monoclonal antibody on cell extracts 
prepared  from  embryos coinjected with  mRNA  and  35S- 
Trans-label mixture. The truncated N- and NXB-cadherins 
contain the same extracellular domain carrying the VSVG-16 
epitope specifically recognized by this monoclonal antibody. 
The truncated  N-cadherin  (Fig.  8  A)  and  NXB-cadherin 
(Fig. 8 B) are able to coprecipitate the three known c~-, ~, 
and ,y-catenins (arrows). The autoradiography was scanned, 
and the band intensity value corresponding to each truncated 
cadherin and catenin was calculated. The ratio between the 
band intensity of the truncated cadherin and/3-catenin was 
determined. The ANcad//3-catenin and ANXBcad//3-catenin 
ratios were 1.6 and 0.75, respectively. This suggests that the 
cytoplasmic domain of ANXB-cadherin has more affinity for 
/5-catenin than that of AN-cadherin, and it might account for 
the stronger perturbation effects obtained from the truncated 
NXB-cadherin expression on embryonic development. 
The Journal of Cell Biology, Volume  127, 1994  530 Figure  7.  Sections of a stage 23NF embryo injected with pANXBcad mRNA and/3-galactosidase mRNA (A), with pANXBcad mRNA 
(B and C), or with pANcadNCAM mRNA (D). In A, the embryo was processed for X-gal staining before sectioning. The sections are 
stained with the anti-N-CAM polyclonal antibody (B), and with the P5D4 monoclonal antibody directed against the epitope "tag" (C and 
D). (A) Many/3gal-positive  cells are seen in the diencephalon, in the optic vesicle, and in the cement gland. Note that these cells do not 
have a radial arrangement (arrowheads),  as compared to their unlabeled or very weakly labeled neighbors. Most strongly labeled/3gal- 
positive cells are found as clusters at the vicinity of the eye cup (arrows),  a few are also seen in the lumen of the central nervous system. 
(B) These cells (arrows),  as well as all the neuroepithelial cells, express N-CAM. (C) The truncated cadberin was mostly detected in 
the intensely labeled/3gal-positive  cells outside the optic cup. (D) The truncated N-CAM is expressed in a number of well-organized neu- 
roepithelial cells. Bar, 50 #m in A, B, and C, and 30/~m in D. de,  diencephalon; ov, optic vesicle; ce, cement gland. 
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of the Different mRNAs 
Percent of embryos 
with cell release 
Number of 
RNA injected  cases  (In)  (hn) 
ANXBcad5 x  36  30.5 
ANXBcadl x  47  17 
ANXBcad0.1 x  34  5.9 
ANcad5 x  27  3.7 
Acadl x  68  13.2 
ANcad0.1 x  25  4 
ANcadNCAM5 x  25  0 
ANcadNCAM1 x  12  0 
the retina.  (b) Different grades of pertubations are obtain- 
ed after  pANXBcad  or  pANcad  mRNA  injections.  The 
pANXBcad mRNA injections preferentially induced abnor- 
mal optic cup morphogenesis, whereas pANcad mRNA in- 
jections affect mainly the organization of the retinal layers. 
(c) The truncated XB- and N-cadherins have additive effects 
52.8  in generating developmental abnormalities. (d) The cells ex- 
19.2  pressing  high  levels of the  truncated  cadherins  segregate 
0  from the neural tissue and are found as clusters in the head 
14.8  mesenchyme.  They coexpress N-CAM  and  remain as  ag- 
1.5  gregates in the head during later development. (e) The cyto- 
0  plasmic domain of truncated NXB-cadherin seems to bind  0 
0  more efficiently to/~-catenin than that of truncated N-cad- 
herin. 
The 0.1 x, 1  ×, and 5  x concentrations  correspond  to 0.025 ng, 0.25 ng, and 
1.25 ng of mRNA  injected  per blastomere,  respectively.  In, one to several  tens 
of cells released; hn, one to several hundreds of cells released. 
Discussion 
In the present study,  we have generated eDNA constructs 
coding for the XB- and N-cadherins truncated in their ex- 
tracellular domains to analyze the roles of these molecules 
during  early  embryogenesis in Xenopus laevis. A  control 
construct  consisted  as  a  hybrid  between  N-cadherin  and 
N-CAM in which the transmembrane and cytoplasmic se- 
quences of the truncated N-cadherin were replaced by those 
of Xenopus N-CAM. The mRNA encoding these truncated 
molecules were injected into the four animal dorsal blasto- 
meres of 32-cell stage embryos. We have observed the follow- 
ing:  (a) During neurogenesis, the injected embryos display 
abnormal development of anterior  structures,  particularly 
Figure  8. Catenins interact with truncated cadherins in injected em- 
bryos, mRNA were coinjected with 35S-Trans-label mixture at the 
two-cell stage of Xenopus embryos.  At stage  13-13.5NF, the em- 
bryos were homogenized in SDS-free immunoprecipitation  buffer 
and incubated with P5D4 monoclonal antibody. The radiolabeled 
proteins immunoprecipitated  were loaded on 7.5 % acrylarnide gel 
and  revealed  by autoradiography.  The catenins  (arrows) copre- 
cipitating  with the truncated  N-cadherin  and NXB-cadherin  (ar- 
rowheads) were shown respectively on lanes A and B. Molecular 
weight markers were indicated on the left. 
Truncated Cadherins Induced Developmental Defects 
in Anterior Structures 
XB- and N-cadherin were chosen here because they display 
specific and different expression patterns during early devel- 
opment of the nervous system. XB-cadherin is already ex- 
pressed at the blastula stage (Herzberg et al.,  1991).  Later, 
its expression declines in the nervous system, while it ap- 
pears  pronounced  in  the  cement  gland  and  becomes  re- 
stricted  to  different  epithelia  (Wedlich,  D.,  unpublished 
results). N-cadherin appears in the neuroectoderm after neu- 
ral induction (Detrick et al., 1990; Simmoneau et al., 1992). 
This molecule is mainly expressed in the brain,  placodes, 
retina, and some mesodermal derivatives during later devel- 
opment. 
In contrast to previous studies, we have restricted the site 
of injection  of the  truncated  cadherin  mRNA to  the  four 
blastomeres of the 32-cell stage that contribute extensively 
to anterior neural structures (Dale and Slack,  1987;  Jacob- 
son and Hirose,  1981;  Moody,  1987).  Injection of mRNAs 
coding for truncated cadherin induces cell release at stage 
13NF in the ectodermal cell layers and generates different 
abnormalities during later development. We have observed 
through the morphological appearance of the injected em- 
bryos and through whole-mount immunostaining performed 
with a monoclonal antibody against N-CAM that significant 
malformations of the anterior neural structures during early 
development existed without any distinguishable alteration 
of other structures.  The malformations are restricted to the 
tissues derived from the injected blastomeres. 
The expression of truncated NXB-cadherin gives rise to 
pronounced defects in anterior neural structures occurring 
though a relatively small number of cells were expelled at 
earlier  stage.  The  expression  of a  truncated  N-cadherin 
resulted primarily in small defects such as alterations in the 
organization of  the cell layers of the retina. These effects can- 
not be solely explained by differences in the number of cells 
released at the earlier stages, but can be explained mainly 
by the fact that cells expressing the truncated cadherins per- 
turb  further development of the nervous system and other 
cranial structures.  This is caused by their altered adhesive 
properties that do not permit their ordered assembly with 
nonperturbed cells into each tissue. Several kinds of pertur- 
bation experiments have shown that morphogenesis cannot 
easily be perturbed by the loss of cells or the arrest of cell 
division. For example, at the 32-cell stage, bilateral ablation 
of the  A1  blastomere,  which  contributes  to  50%  of the 
retina, still results in a majority of tadpoles with either nor- 
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Moody, 1993). On the other hand, the surgical removing of 
half of the embryonic eye bud including the proliferative 
zone portion (Wetts et al.,  1993) gives rise to normal eye 
morphogenesis and structure with only a  reduction in the 
final size. It was also observed that the blocking of cell divi- 
sion by hydroxyurea and aphidicolin, as early as stage 10NF, 
did not prevent morphogenesis and differentiation to occur 
in the nervous system, although it contains many less cells 
(Harris and Hartenstein,  1991). 
Anterior neural tissues are always present in our injected 
embryos, even if they appear to be abnormal in their organi- 
zation. Therefore, as previously observed in blastomere ab- 
lation experiments (Huang and Moody, 1993), blastomeres 
other than the four animal dorsal can contribute to the an- 
terior neural system. In our case, the possible contribution 
of other blastomeres than those injected to give rise to ner- 
vous tissue appears to be not sufficient to allow a proper res- 
cue of aberrant neural structures. Eye morphogenesis is one 
of the targets of the pertubation, and it is dependent on the 
blastomeres injected and on the type of mRNA used. These 
defects are sometimes associated with hyperplasia of other 
neural structures,  such as the brain and the olfactory pla- 
codes, particularly when mRNA coding for other truncated 
cadherins were injected (Broders, E, J. M. Girault, and J. P. 
Thiery, manuscript submitted for publication). 
Anterior Defects Appear Only at the Early 
Neurula Stage 
The primary target proteins in competition with truncated 
cadherins for catenin binding might be represented by the 
maternal cadherins. One would expect that the function of 
XB-cadherin and EP-cadherin should be affected equally by 
injection of  pAXBNcad mRNA because these isoforms share 
a sequence similarity of 93 % in their cytoplasmic domain. 
In comparison to their expression pattern (Angres et al., 
1991),  the perturbations appear relatively late in develop- 
ment when E-cadherin is also present. XB-cadherin and EP- 
cadherin are abundant, maternally derived proteins, and they 
are expressed de novo during midblastula transition. Besides 
this  store of cadherins,  ~  and /5-catenins  are also  found 
maternally expressed and in particular free ot-catenin is in 
excess during early embryogenesis (Schneider et al., 1993). 
This relative high concentration of cadherins and catenins 
might impede successful competition by truncated cadherins 
at earlier stages (blastula/gastrula). The observed perturba- 
tions at the neurula stage correlate with the declining expres- 
sion of XB- and EP-cadherins (Ginsberg et al.,  1991; Levi 
et al.,  1991a) and the decrease of free a-catenin (Schneider 
et al.,  1993), while the truncated cadherins are extremely 
stable at least until stage 25NE 
Differential Effect of Cytoplasmic Domains 
of Cadherins and Possible Mechanisms 
At the equivalent of stage 13NE the truncated cadherins in- 
duced disruption of intercellular contacts in the ectodermal 
layers of the embryos. In our hands,  the truncated N-cad- 
herin was able to induce dissociation at stages where the en- 
dogenous N-cadherin is not yet expressed (Detrick et al., 
1990), suggesting,  as previously reported (Kintner,  1992), 
that it can interfere with the early cadherins such as XB-, U-, 
and  E/P-cadherins (Angres  et al.,  1991;  Ginsberg et al., 
1991;  Herzberg et al.,  1991; Levi et al.,  1991a).  Interest- 
ingly, the extent of cell release depends essentially on the 
type and concentration of mRNA  injected.  The truncated 
NXB-cadherin is more efficient than the truncated N-cad- 
herin in inducing cell disruption, and this is consistent with 
the  presence of this  molecule at  the  stage  at  which  cell 
dissociation is observed. The coinjection of both pANcad 
and pANXBcad mRNA at lx  concentration have additive 
effects in promoting cell release and developmental defects. 
In  contrast,  the  control pANcadNCAM  hybrid construct 
did  not  induce  cell  release.  Besides  the  inability  of the 
pANcadNCAM hybrid to induce cell release, the fact that 
pANcad and pANXBcad possess the same transmembrane 
domain clearly indicates that the disruptive effects are depen- 
dent on the cytoplasmic domain of these cadherins. The ob- 
servation that the cytoplasmic domains of XB- and N-cad- 
herin show distinct and additive disruptive activities could 
be explained by the fact that the cytoplasmic domains of the 
two  cadherins  share only 60%  partial  identity sequence. 
It is, therefore, possible that a given cadherin cytoplasmic 
domain competes specifically or more efficiently  with the en- 
dogenous cadherin of the same type for the binding of eat- 
enins. Our truncated cadherins bind the three known a-,/3-, 
and 3,-catenins,  keeping with the fact that these catenins do 
not exhibit specificity to different cadherins (Ozawa et ai., 
1989; Ozawa and Kemler, 1992; Herrenknecht et al., 1991). 
However, the truncated NXB-cadherin binds more efficiently 
/3-catenin that the truncated N-cadherin. This suggests that 
distinct cadherin-cytoplasmic domains can differently titer 
this component, critical for the proper functioning of endog- 
enous cadherins (McCrea et al.,  1993; Peifer et al.,  1993; 
Schneider et al.,  1993), and can explain the differential em- 
bryonic defects obtained for pANcad and pANXBcad mRNA 
injected embryos. On the other hand, the titration of one of 
the components involved in the complex assembly of cad- 
herins and catenins, into a higher order structure, may be 
also  more  effective with  one  truncated  cadherin  species 
(Kemler, 1993; McCrea et al.,  1993). However, we did not 
observe specific components selectively coprecipitated by 
N- or NXB-truncated cadherin. We cannot exclude the pos- 
sibility that the truncated cadherins also compete for the oc- 
cupancy of  natural sites, where the endogenous cadherins are 
found, as previously reported in an in vitro assay (Fujimori 
and Takeichi, 1993), or that other unidentified cytoplasmic 
ligands might exist that specifically bind to a given cadherin 
molecule that could not be detected by classical biochemical 
approaches. 
Other Adhesion Systems 
Cells expressing high levels of truncated cadherins, as de- 
tected by the expression of the "tag" epitope,  are mainly 
found in the vicinity of the neural tissue. These cells still ex- 
press N-CAM, indicating that they are capable of acquiring 
neural characteristics and furthermore that N-CAM is not 
sufficient to maintain these cells within the neural tissue. 
The N-CAM and cadherins, therefore, do not seem to com- 
plement each other, but they appear to be required to stabi- 
lize neural tissue integrity. This could reflect the additivity 
of adhesive forces operating between cells or, alternatively, 
the addition of distinct cytoplasmic signaling  systems re- 
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(Doherty et al.,  1991).  Expression of high level of the trun- 
cated NcadNCAM  hybrid protein in Xenopus embryos can 
induce at low frequency embryonic defects of anterior struc- 
tures.  This hybrid  carries the NCAM  140-kD  cytoplasmic 
domain. A cytoplasmic ligand has not been described so far 
to interact  with this cytoplasmic form of NCAM,  whereas 
the cytoplasmic domain corresponding to the NCAM  180- 
kD form has been shown to interact  with spectrin (Pollen- 
berg et al., 1986, 1987). It would be interesting to investigate 
the effect of the expression of the 180-kD-truncated variant 
of NcadNCAM  hybrid on cell adhesion and embryonic de- 
velopment. Furthermore,  the coexpression of truncated cad- 
herins and several types of NcadNCAM hybrids would allow 
a better understanding  of NCAM cytoplasmic domain func- 
tion and the possible cross-talk between these two cell-adhe- 
sion systems during embryogenesis. 
The combination of the use of dominant-negative mutants 
of cadherins with the restriction of the sites of injection of 
these constructs provides evidence for the notion that their 
cytoplasmic  domains  play  a  role in the  specificity  of the 
adhesive functions of the cadherins.  It is intriguing to con- 
sider the possibility that the cytoplasmic domain of cadhe- 
rins bear specific functions to transduce  signals leading to 
different  morphogenetic events.  Such  a  situation  has been 
clearly established for several integrin cytoplasmic domains 
in cell migration,  cell proliferation, and collagen gel con- 
traction  (Chan et al.,  1992;  Pasqualini  and Hemler,  1994). 
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